Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3929]
News [11457]
Articles [47]
Editorials [10]
Conferences [201]
elearning [4]
Carfilzomib combinations in ENDEAVOR and FORTE
Prof Katja Weisel - University of Tübingen, Tübingen, Germany
Carfilzomib combinations in ENDEAVOR and FORTE ( Prof Katja Weisel - University of Tübingen, Tübingen, Germany )
23 Jun 2017
Deep molecular response to gilteritinib in CHRYSALIS trial
Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern...
Deep molecular response to gilteritinib in CHRYSALIS trial ( Dr Jessica Altman - Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA )
23 Jun 2017
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Dual JAK/SYK inhibition in refractory NHL with cerdulatinib ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Diverse T lymphocyte population fights leukaemia more effectively
Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany
Diverse T lymphocyte population fights leukaemia more effectively ( Dr Michaela Kotrova - University Hospital Schleswig-Holstein, Kiel, Germany )
23 Jun 2017
Delayed exposure to common infections causes acute childhood leukaemia
Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical...
Delayed exposure to common infections causes acute childhood leukaemia ( Dr Julia Hauer - Clinic for Pediatric Oncology, Haematology and Clinical Immunology, Düsseldorf, Germany )
23 Jun 2017
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed...
Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA
Cerdulatinib demonstrates rapid responses in a phase 2 study for relapsed/refractory NHL ( Dr Paul Hamlin - Memorial Sloan Kettering Cancer Center, NY, USA )
23 Jun 2017
Improving outcomes for oestrogen receptor positive breast cancer
Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy
Improving outcomes for oestrogen receptor positive breast cancer ( Dr Giancarlo Pruneri - European Institute of Oncology, Milan, Italy )
19 Jun 2017
Translational research: from bench to bedside
Prof Peter Selby - Leeds University, Leeds, UK
Translational research: from bench to bedside ( Prof Peter Selby - Leeds University, Leeds, UK )
19 Jun 2017
The European Alliance for Personalised Medicine
Denis Horgan - European Alliance for Personalised Medicine, Belgium
The European Alliance for Personalised Medicine ( Denis Horgan - European Alliance for Personalised Medicine, Belgium )
19 Jun 2017
EUPATI and patient involvement
Paola Kruger - Patient Expert, EUPATI Fellow
EUPATI and patient involvement ( Paola Kruger - Patient Expert, EUPATI Fellow )
19 Jun 2017
ESMO ranking of the clinical benefits of new drugs
Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy
ESMO ranking of the clinical benefits of new drugs ( Prof Alberto Sobrero - Ospedale San Martino, Genova, Italy )
19 Jun 2017
Cancer and the workplace
Prof Diana Kloss - Manchester University, Manchester, UK
Cancer and the workplace ( Prof Diana Kloss - Manchester University, Manchester, UK )
19 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation